- Anti-Heparin-Platelet Factor 4 Antibody is a Risk Factor for Vascular Access Obstruction in Patients Undergoing Hemodialysis
-
Lee EY, Hwang KY, Yang JO, Hong SY
- KMID: 1099796
- J Korean Med Sci.
- 2003 Feb;18(1):69-72.
- doi: 10.3346/jkms.2003.18.1.69
Since heparin is an anticoagulant commonly used in hemodialysis and the patients on hemodialysis are repeatedly exposed to heparin, heparin may be the cause of the development of heparin-dependent antibodies... -
- CITED
-
- Close
- SHARE
-
- Close
- Utility of ELISA Optical Density Values and Clinical Scores for the Diagnosis of and Thrombosis Prediction in Heparin-induced Thrombocytopenia
-
Kim SY, Kim HK, Han KS, Kim I, Yoon SS, Park S, Kim BK
- KMID: 1096652
- Korean J Lab Med.
- 2011 Jan;31(1):1-8.
- doi: 10.3343/kjlm.2011.31.1.1
BACKGROUND: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction caused by antibodies to the heparin/platelet factor 4 (PF4) complex, resulting in thrombocytopenia and prothrombotic state. HIT diagnosis is challenging and... -
- CITED
-
- Close
- SHARE
-
- Close
- The Incidence, Causes, and Prognostic Significance of New-Onset Thrombocytopenia in Intensive Care Units: A Prospective Cohort Study in a Korean Hospital
-
Lim SY, Jeon EJ, Kim HJ, Jeon K, Um SW, Koh WJ, Chung MP, Kim H, Kwon OJ, Suh GY
- KMID: 2157956
- J Korean Med Sci.
- 2012 Nov;27(11):1418-1423.
- doi: 10.3346/jkms.2012.27.11.1418
This study was designed to investigate the incidence, causes, and outcomes of new-onset thrombocytopenia (NOT) in Korean intensive care units (ICUs). A prospective cohort study was conducted in medical ICUs... -
- CITED
-
- Close
- SHARE
-
- Close
